Paritaprevir
Drug · tier A · 8 trials (0 recruiting) · 16 publications · score 78.5
Ombitasvir
Drug · tier A · 8 trials (0 recruiting) · 16 publications · score 77.5
Ledipasvir
Drug · tier A · 8 trials (0 recruiting) · 15 publications · score 76.5
Ritonavir
Drug · tier A · 8 trials (0 recruiting) · 16 publications · score 74.5
Sofosbuvir
Drug · tier A · 8 trials (0 recruiting) · 16 publications · score 74.0
Cyclosporine
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 70.0
Sodium Chloride
Drug · tier A · 8 trials (0 recruiting) · 0 publications · score 39.0
Disulfiram
Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 27.0
Candesartan Cilexetil
Drug · tier A · 2 trials (1 recruiting) · 0 publications · score 26.5
Angiotensin Ii
Drug · tier A · 1 trials (0 recruiting) · 2 publications · score 26.0
Betaine
Drug · tier A · 3 trials (0 recruiting) · 1 publications · score 26.0
Losartan Potassium
Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 24.5
Dexamethasone
Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 21.0
Research map, not treatment advice. Built 2026-10-07.